Trilegal is a full service law firm with offices in Bengaluru, Delhi, Gurugram and Mumbai. We have been consistently recognised as the best Indian multi-practice law firm for the quality of our services and client satisfaction. The firm’s all-equity lockstep model, based on transparency, democracy and meritocracy, is unique in India. We are proud that the firm has been recognised for its commitment to diversity, equality and sustainability. We are a leading law firm with a reputation for consistent excellence. We provide a vibrant and inclusive work environment built on a foundation of professionalism and a commitment to providing our people with all opportunities to grow and excel. Our core values of respect, integrity and professionalism define our identity. Our corporate practice comprises several specialist teams, each with deep expertise and a strong market reputation, that advise Indian and multinational clients on a range of transactions relating to mergers and acquisitions, joint ventures, private equity transactions, as well as high-value debt restructuring, distressed asset management, special situations, and insolvency matters. We advise on inbound and outbound mergers and acquisitions, joint ventures, entry strategy and strategic alliances as well as transactions arising out of corporate restructuring and involving Special Purpose Acquisition Companies. We work with domestic and international investors, banks, promoters and entrepreneurs and advise them on the considerations involved in structuring, drafting, and negotiating mergers, acquisitions and joint ventures. Our unique business model enables us to extend this advice across areas such as intellectual property, competition aspects, regulatory concerns, real estate, tax, and labour and employment. Firm Profile Divestment of Majority Stake in Glenmark Life Sciences by Glenmark Pharma to Nirma Trilegal represented Glenmark Life Sciences Limited (“GLS”), a listed pharmaceutical manufacturer of APIs, in the proposed sale of 75% equity shares of GLS by Glenmark Pharmaceuticals Limited to Nirma Limited. The proposed share sale is for an aggregated consideration of INR 56.51 billion, subject to customary closing adjustments. The transaction is subject to a mandatory open offer to be made by Nirma Limited, customary conditions precedent, including but not limited to lender consents, regulatory and shareholder approvals. The Trilegal team was led by Partner and National Head of Corporate Practice, Yogesh Singh, along with Tejas Adiga (Corporate) and Atul Gupta (Labour and Employment). Other attorneys who supported the deal include Kosha Thaker, Counsel; Arunima Singal and Rohan Kohli, Senior Associates; Daksha Khanna, Abhijit Bhandarkar, Adit Munshi and Nikita Rajesh, Associates on corporate aspects; and Parvathy Tharamel, Counsel, on employment law matters. www.trilegal.com Finance Monthly Deal Maker Awards 2024. INDIA 69
RkJQdWJsaXNoZXIy Mjk3Mzkz